Nottingham, United Kingdom

Hayley Tegan Angela Watson

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hayley Tegan Angela Watson: Innovator in Kinase Inhibitors

Introduction

Hayley Tegan Angela Watson is a notable inventor based in Nottingham, GB. She has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing scientific knowledge.

Latest Patents

Watson holds a patent for "Pyrazolyl-ureas as kinase inhibitors." This patent includes compounds of formula I, which are designed to inhibit specific kinases, potentially leading to new therapeutic options for various diseases. Her work in this area highlights her commitment to addressing critical health challenges through innovative solutions. She has 1 patent to her name.

Career Highlights

Throughout her career, Watson has worked with prominent companies in the pharmaceutical industry. She has been associated with Respivert Limited and Topivert Pharma Limited, where she has contributed her expertise in drug development and research. Her experience in these organizations has allowed her to collaborate with leading professionals in the field.

Collaborations

Watson has worked alongside talented individuals such as Claire Anne Marie Cariou and Catherine Elisabeth Charron. These collaborations have enriched her research and contributed to the advancement of innovative solutions in the pharmaceutical sector.

Conclusion

Hayley Tegan Angela Watson is a distinguished inventor whose work in kinase inhibitors has the potential to impact the medical field significantly. Her dedication to innovation and collaboration with industry professionals underscores her role as a key contributor to scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…